Tradestie Institutional Equity Comparison Engine

PACB vs VVOS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PACB Overall Edge

PACB Captures Institutional Edge (2โ€“1 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Pacific Biosciences of California, Inc. (PACB) driven by superior Momentum & Technical, Options & Structure while VVOS counters with relative strength in Growth & Margin. Fundamentally, PACB trades at N/M Forward P/E with -333.0% operating margin (+5.5% YoY revenue) versus VVOS at N/M Forward P/E and -107.9% operating margin (+34.9% YoY). In options structure, PACB sits in BREAKDOWN (97th %ile IV; Dealer Gamma Walls on Pro) against VVOS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
PACB N/M vs VVOS N/M Fwd P/E
Growth & Margin Winner VVOS
Op Margin -333.0% vs -107.9% ยท YoY +5.5% vs +34.9%
Momentum & Technical Winner PACB
1Y -7.4% vs -97.7% ยท 52W Pos 24% vs 0%
Options & Structure Winner PACB
BREAKDOWN (97th %ile IV) vs BREAKDOWN (N/A IV)
PACB NASDAQ
Pacific Biosciences of California, Inc.
Laboratory Analytical Instruments
$1.63
-7.39% 1D
Market Cap $549.5M
1M Return -20.87%
1Y Return -7.39%
Forward P/E N/M
Unified AI Score
50.1 / 100 HOLD
Tech 40.0 Fund 55.0 Flow 70.0 Mom 60.0
VVOS NASDAQ
Vivos Therapeutics, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.05
-5.1% 1D
Market Cap $1.9M
1M Return -59.25%
1Y Return -97.71%
Forward P/E N/M
Unified AI Score
36.4 / 100 SELL
Tech 25.0 Fund 35.0 Flow 50.0 Mom 30.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PACB -7.39% VVOS -97.71% Spread: +90.32 pp (PACB Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period PACB Revenue VVOS Revenue PACB Op. Margin VVOS Op. Margin Margin Edge
FY2018 $80M N/A -128.4% N/A PACB
FY2019 $90M $10M -110.6% -92.8% VVOS
FY2020 $80M $10M -132.3% -92.1% VVOS
FY2021 $130M $20M -161.2% -120.7% VVOS
FY2022 $130M $20M -239.4% -156.2% VVOS
FY2023 $200M $10M -166.8% -125.3% VVOS
FY2024 $150M $20M -308.0% -74.3% VVOS
FY2025 $160M $20M -346.2% -114.1% VVOS

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PACB (6) vs VVOS (2)
Institutional Metric PACB VVOS Criterion Row Winner
Market Capitalization Scale $549.5M $1.9M Larger Scale PACB
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +5.5% +34.9% Higher Growth VVOS
Operating Margin (TTM) Profitability -333.0% -107.9% Higher Margin VVOS
Net Profit Margin Profitability -81.3% -121.8% Higher Margin PACB
Return on Equity (ROE) Capital Efficiency -929.3% -8585.3% Higher ROE PACB
52-Week Range Position Momentum 24% ($1โ€“$3) 0% ($0โ€“$3) Stronger Trend PACB
Beta / 30D Volatility Risk Regime 2.25ฮฒ ยท 104% Vol 1.70ฮฒ ยท 111% Vol Lower Realized Risk PACB
Unified Institutional Score Composite Signal 50.1 / 100 (HOLD) 36.4 / 100 (SELL) Higher Composite PACB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PACB vs VVOS Buy Guide
PACB BREAKDOWN
16d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 97th %ile
IV Regime Extreme (>80th %ile)
Live PACB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VVOS BREAKDOWN
113d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live VVOS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PACB nor VVOS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.